APAC Telemedicine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Asia-Pacific Top Telemedicine Companies and the market is segmented By Type (Tele hospitals, Tele homes, mHealth), By Component ((Product (Hardware, Software, and Other Products) and Services (Telepathology, Telecardiology, Teleradiology, Tele dermatology, Telepsychiatry, and Other Services)), By Mode of Delivery (On - premise Delivery and Cloud - based Delivery), and Geography (China, Japan, India, Australia, South Korea, and Rest of Asia - Pacific). The market provides the value (in USD million) for the above-mentioned segments.

Asia-Pacific Telemedicine Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
View Global Report
APAC Telemedicine-1
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 35.46 Billion
Market Size (2029) USD 70.13 Billion
CAGR (2024 - 2029) 14.61 %

Major Players

Asia-Pacific Telemedicine Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Asia-Pacific Telemedicine Market Analysis

The Asia-Pacific Telemedicine Market size is estimated at USD 35.46 billion in 2024, and is expected to reach USD 70.13 billion by 2029, growing at a CAGR of 14.61% during the forecast period (2024-2029).

Owing to the current Pandemic Situation Asia-Pacific telemedicine is poised to grow owing to the rapid adoption of digital and smart health due to the current social distancing and lockdown protocol in this region. In October 2020, a white paper on technology-led transformation in Indian health care, released by the New Delhi-based Associated Chambers of Commerce and Industry of India stated that rapid migration to digital technologies is marked less by a strategic plan or roadmap and more by the urgency of decision-making due to the pandemic.

Factors such as a rise in healthcare costs, increasing remote patient monitoring, technological innovations, and a growing burden of chronic diseases in the Asia-Pacific region are augmenting the growth of the market.

In October 2020, The Ministry of Civil Affairs in China has predicted that the country's senior population is expected to reach 300 million in five years i.e., between the period 2021-2026, marking a demographic transition to a moderately aging society. And by around 2040, there will be more than 400 million seniors and fewer babies. This has become a serious concern for the Chinese ministry as an upcoming surge in the aging population is expected to increase the burden of various chronic diseases in the country.

With the increasing aging population and prevalence of chronic diseases in the Asia-Pacific region, there is a growing need for finding new ways that increase access to care and reduce the cost of medical care to improve patient outcomes. Using remote patient monitoring, which utilizes devices to remotely collect and direct information to a remote diagnostic testing facility for interpretation, the healthcare providers, insurance payers, and governments are looking to alter the way care is being delivered and at the same time reducing the cost of care. For instance, in November 2019, Royal Melbourne Institute of Technology (RMIT) partnered with the European Connected Health Alliance (ECHAlliance) and launched a digital health ecosystem in Australia to strengthen the connections between patients, clinicians, researchers, policymakers, technology providers, and the community. Therefore, owing to all the above-mentioned factors it is indicated that the telemedicine market will grow exponentially in the Asia-Pacific region.

Asia-Pacific Telemedicine Market Trends

This section covers the major market trends shaping the APAC Telemedicine Market according to our research experts:

mHealth Segment is Expected to Witness Rapid Growth Rate in the Asia-Pacific Telemedicine Market

mHealth is an abbreviation of mobile health concerned with the practice of public health and or medicine supported by mobile devices. The rapid advances in mobile technologies and applications, a rise in new opportunities for the integration of mobile health into existing eHealth services, and the continued growth in coverage of mobile cellular networks are expected to boost the market growth.

In June 2020, the Health Ministry of Japan reported that Japan's COVID-19 contact-tracing app has reached more than 4 million downloads in a week. In addition, in April 2020, Malaysia launched the MySejahtera app, aimed at helping the government to contain the COVID-19 outbreak, and at the same time enabling users to monitor their health during the pandemic. By August 2020, the app had been downloaded by 13.3 million users.

In addition, the rise of chronic diseases is a major concern in the Asia-Pacific region that is increasing the adoption of several mHealth applications in order to monitor health outcomes. For instance, according to the research article published in the Journal for Cardiovascular Quality and Outcomes, 2019, the estimated prevalence of Cardiovascular diseases (CVDs) in India was estimated to be 54.5 million, and one in 4 deaths in India is because of CVDs, with ischemic heart disease and stroke being responsible for more than 80% of this burden. Thus, the presence of above-mentioned market development factors are contributing to the increased adoption of these services thereby, driving the growth of the telemedicine market.

USD

Asia-Pacific Telemedicine Industry Overview

The Asia-Pacific Telemedicine Market is moderately consolidated, owing to the presence of many small and large market players. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products or services with fewer prices. It is expected that in the coming future, these companies will have a substantial share of the market studied. The key players of the market are Allscripts Healthcare Solutions, Inc., InTouch Technologies Inc., Resideo Technologies Inc., and Aerotel Medical Systems.

Asia-Pacific Telemedicine Market Leaders

  1. Allscripts Healthcare Solutions, Inc.

  2. InTouch Technologies Inc.

  3. Resideo Technologies Inc.

  4. AMD Global Telemedicine Inc.

  5. Aerotel Medical Systems

*Disclaimer: Major Players sorted in no particular order

Asia tele landscape.png
Need More Details on Market Players and Competitors?
Download PDF

Asia-Pacific Telemedicine Market News

In October 2020, Columbia Asia Hospital group launched a telehealth service that provides various services including doctor via video call, medical advice, and/or clinical management as well as drug prescriptions.

In May 2020, IHH Healthcare, one of Asia's largest privately-owned healthcare group, launched telemedicine services in Singapore, Malaysia, Turkey, India, and Hong Kong.

Asia-Pacific Telemedicine Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Healthcare Expenditure
    • 4.2.2 Technological Innovations
    • 4.2.3 Increasing Remote Patient Monitoring
    • 4.2.4 Growing Burden of Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 Legal and Reimbursement Issues
    • 4.3.2 High Initial Capital Requirements and Lack of Physician Support
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Telehospitals
    • 5.1.2 Telehomes
    • 5.1.3 mHealth (mobile health)
  • 5.2 By Component
    • 5.2.1 Products
    • 5.2.1.1 Hardware
    • 5.2.1.2 Software
    • 5.2.1.3 Other Products
    • 5.2.2 Services
    • 5.2.2.1 Telepathology
    • 5.2.2.2 Telecardiology
    • 5.2.2.3 Teleradiology
    • 5.2.2.4 Teledermatology
    • 5.2.2.5 Telepsychiatry
    • 5.2.2.6 Other Services
  • 5.3 By Mode of Delivery
    • 5.3.1 On-premise Delivery
    • 5.3.2 Cloud-based Delivery
  • 5.4 Geography
    • 5.4.1 China
    • 5.4.2 Japan
    • 5.4.3 India
    • 5.4.4 Australia
    • 5.4.5 South Korea
    • 5.4.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Aerotel Medical Systems Ltd
    • 6.1.2 Allscripts Healthcare Solutions Inc.
    • 6.1.3 AMD Global Telemedicine Inc.
    • 6.1.4 Biotelemetry
    • 6.1.5 Cerner Corporation
    • 6.1.6 General Electric Incorporated
    • 6.1.7 InTouch Technologies Inc.
    • 6.1.8 Koninklijke Philips NV
    • 6.1.9 Medtronic PLC
    • 6.1.10 Resideo Technologies Inc.
    • 6.1.11 SHL Telemedicine
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject To Availablity
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Asia-Pacific Telemedicine Industry Segmentation

As per the scope of this report, telemedicine services and systems have made the most progress in the remote management of post-acute care patients with chronic conditions. Telemedicine is the remote delivery of healthcare services, such as consultations over telecommunication or teleconference, and it allows healthcare professionals to evaluate, diagnose, and treat patients. The Asia-Pacific Telemedicine Market is segmented By Type (Telehospitals, Telehomes, mHealth ), By Component ((Product (Hardware, Software, and Other Products) and Services (Telepathology, Telecardiology, Teleradiology, Teledermatology, Telepsychiatry, and Other Services)), By Mode of Delivery (On-premise Delivery and Cloud-based Delivery), and Geography (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific). The market report also covers the estimated market sizes and trends for different countries across major regions in Asia-Pacific. The report offers the value (in USD million) for the above segments.

By Type Telehospitals
Telehomes
mHealth (mobile health)
By Component Products Hardware
Software
Other Products
By Component Services Telepathology
Telecardiology
Teleradiology
Teledermatology
Telepsychiatry
Other Services
By Mode of Delivery On-premise Delivery
Cloud-based Delivery
Geography China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Need A Different Region Or Segment?
Customize Now

Asia-Pacific Telemedicine Market Research FAQs

The Asia-Pacific Telemedicine Market size is expected to reach USD 35.46 billion in 2024 and grow at a CAGR of 14.61% to reach USD 70.13 billion by 2029.

In 2024, the Asia-Pacific Telemedicine Market size is expected to reach USD 35.46 billion.

Allscripts Healthcare Solutions, Inc., InTouch Technologies Inc., Resideo Technologies Inc., AMD Global Telemedicine Inc. and Aerotel Medical Systems are the major companies operating in the Asia-Pacific Telemedicine Market.

In 2023, the Asia-Pacific Telemedicine Market size was estimated at USD 30.94 billion. The report covers the Asia-Pacific Telemedicine Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Telemedicine Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Asia-Pacific Telemedicine Industry Report

Statistics for the 2024 Asia-Pacific Telemedicine market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. Asia-Pacific Telemedicine analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

APAC Telemedicine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)